The autophagy lysosome pathway is essential to maintain cell viability and homeostasis in response to many stressful environments, which is reported to play a vital role in cancer development and therapy. However, the association of genetic alterations of this pathway with risk of cancer remains unclear. Based on genome-wide association study data of eight kinds of cancers, we used an adaptive rank truncated product approach to perform a pathway-level and gene-level analysis, and used a logistic model to calculate SNP-level associations to examine whether an altered autophagy lysosome pathway contributes to cancer susceptibility. Among eight kinds of cancers, four of them showed significant statistics in the pathway-level analysis, including breast cancer (p 5 0.00705), gastric cancer (p 5 0.00880), lung cancer (p 5 0.000100) and renal cell carcinoma (p 5 0.00190). We also found that some autophagy lysosome genes had signals of association with cancer risk. Our results demonstrated that inherited genetic variants in the overall autophagy lysosome pathway and certain associated genes might contribute to cancer susceptibility, which warrant further evaluation in other independent datasets.
Introduction
The occurrence of cancer is increasing and cancer has become a significant burden for society, especially in developing countries. 1 Genetic factors partially contribute to the etiology of cancer. In the past few years, the genome-wide association studies (GWASs) have reported numbers of single-nucleotide polymorphisms (SNPs) at specific chromosomal loci that are associated with cancer, and some specific loci, such as 8q24, were established as common cancer susceptibility regions for different kinds of cancers. [2] [3] [4] [5] However, genetic factors not reaching genome-wide significance would be neglected in the typical single-locus analysis of GWAS data. Pathway-based analysis focuses on the biological function and cumulative effects of common variants on diseases, which could provide new insights into the molecular characteristics of cancer. 6, 7 The autophagy lysosome pathway is a degradation process for components such as proteins and organelles, which regulates homeostasis and sustains metabolism. In normal cells and tissues, this pathway is tissue-specific and complicated. 8 Its role in cancer is context-dependent because either inhibitory or promoting effect of autophagy on tumorigenesis or cancer cell proliferation has been reported. 9 Cancer initiation is inhibited by the autophagy lysosome pathway through eliminating damaged protein and organelles, and subsequent reductions in oxidative stress and oncogenic signaling. In contrast, to meet the increased biosynthetic and metabolic demands and overcome the inherent deficiencies in the microenvironment, cancer cells also rely on the autophagy lysosome pathway to recycle intracellular components into energy production. 10 However, the underlying mechanisms of the autophagy lysosome pathway in cancer remain largely unknown.
Given the key role of the autophagy lysosome pathway in cancer initiation or tumor progression, SNPs in genes involved in this pathway could be associated with cancer risk. To date, several SNPs in a few core autophagy lysosome pathway genes have been determined for their relationship with risk of cancer. SNPs in certain autophagy lysosome pathway genes have been shown to be associated with the risk of breast cancer, 11 colorectal cancer (CRC), 12 thyroid carcinoma, 13 gastric cancer (GC), 14 melanoma. 15 In addition, previous studies have also assessed associations between SNPs in the autophagy lysosome pathway and clinical outcome or other clinical characteristics of patients with cancer. [12] [13] [14] [15] [16] However, the number of the included SNPs and the samples were relatively small in most of these studies.
Rather than a few selected SNPs, we used a more comprehensive pathway-based analysis to assess the association between genetic variants of the autophagy lysosome pathway and the susceptibility of eight kinds of cancers in our study. Analyses were carried out using data from the first phase of GWAS. We considered the potential modifying role of the germline genetic alterations of the overall autophagy lysosome pathway on the risk of breast cancer, GC, lung cancer, renal cell carcinoma (RCC) and certain autophagy lysosomerelated genes on the risk of eight cancers.
Materials and Methods

Study population
Our study used the first phase of the previously conducted GWAS data of eight kinds of cancers, including bladder cancer, breast cancer, GC, esophageal squamous cell carcinoma (ESCC), lung cancer, pancreatic cancer, prostate cancer and RCC. 4, 5, [17] [18] [19] [20] [21] The raw data were downloaded from dbGAP (www.ncbi.nlm.nih.gov/gap). Exclusion criteria for the subjects were as follows: 1) SNP completion rate was <94%; 2) gender discordant and 3) duplicate sample. The characteristics of each data set are shown in Table 1 .
Gene and SNP selection
A complete list of 135 genes was constructed in our study, which were identified from the comprehensive autophagy lysosome gene signature (Supporting Information Table  S3 ). 22 These genes include (i) known lysosome proteomics;
(ii) autophagy interactome datasets and (iii) published lysosomal disease-associated genes. [23] [24] [25] [26] The protein-protein interaction network was visualized by STRING (www.stringdb.org/; Fig. 1 ). Four genes on the X chromosome were removed (ATG4A, CLCN5, IDS, LAMP2). SNPs located from the 20 kb upstream to the 10 kb downstream of the respective gene were included in our study. Some SNPs were over counted as the overlap between fragments of genes. The criteria for exclusion of SNPs were as follows: 1) missing rates >10%; 2) minor allele frequency (MAF) <5% (all subjects in each study) and 3) the p-values of the Hardy-Weinberg equilibrium <0.0001 (in controls). Following all SNP exclusions, numbers of SNPs in the different cancers included can be found in Table 1 . In addition, we computed the linkage disequilibrium (LD) between SNPs across the same chromosome.
Statistical analysis
To evaluate potential population admixture or stratification, the EIGENSTRAT program was used to obtain principal component analysis (PCA) for breast cancer, RCC, lung cancer and pancreatic cancer, as no obvious problem with population stratification was observed in the other four kinds of cancers. 4, 5, 17, 27 For each SNP, unconditional logistic regression was performed to calculate odds ratios (ORs) and 95% confidence intervals (CIs) in an additive model; covariates in this model included gender, age and/or family history/study/same number of significant principal components calculated from the EIGENSTRAT program as the original GWAS (Table 1) . For gene-level and pathway-level analyses, we used the adaptive rank truncated product (ARTP) approach, which could effectively yield the best-combined evidence of association for distinct SNPs and genes within a pathway and assess the What's new? The autophagy lysosome pathway is suspected of playing a role in cancer initiation. Whether genetic variants of autophagy lysosome genes are associated with cancer risk, however, remains unclear. In this systematic analysis of datasets from eight genome-wide association studies, germ-line polymorphic variants in the autophagy lysosome pathway were identified as important susceptibility factors specifically for four cancer types: lung cancer, gastric cancer, breast cancer, and renal cell carcinoma. In particular, several genes in the pathway were significantly associated cancers of the breast and lung. The results warrant further investigation of autophagy lysosome pathway involvement in cancer pathogenesis and risk.
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significance through a resampling procedure based on permutation (20,000 times). 5, 28 For SNP-level analysis, we declared statistical significance if p < 0.001; for gene-level and pathway-level calculation, we used p < 0.05 as the statistically significant threshold. R language and Plink v1.07 were used for the statistical analyses.
Results
Individual SNPs associated with cancer risk
Supporting Information Table S1 shows the selected SNPs with p-values <0.001. No SNP was found that reached genome-wide significance in our results. The SNPs confirmed to be related to lung cancer are rs11204949 (CTSK), rs4648135 (MANBA), rs10489113 (MANBA), rs644827 (NEU1), rs2242665 (NEU1), rs660550 (NEU1) and rs660594 (NEU1) (p < 0.001). The pairwise LD of the four SNPs in NEU1 was equally high (r 2 > 0.95), which represented one signal. Five SNPs were associated with breast cancer (Supporting Information Table S1 ). Among the six SNPs significantly related to GC, pairwise LD between rs2049805 (GBA) and rs2990245 (GBA) was high (r 2 5 0.98). In addition,
another six SNPs (rs2712353, rs13061150, rs9828099, rs9865965, rs8181674 and rs1215) were tightly related to RCC, with p < 0.001; the pairwise LD between rs13061150, rs9865965 and rs9828099 in ATP6V1A was high (r 2 > 0.95).
A relatively small number of SNPs was found to be related to the other cancers. In ESCC, prostate cancer and pancreatic cancer, two SNPs showed statistical significance (p < 0.001), rs11064213 and rs12595883 for ESCC, rs2288904 and rs3087969 for prostate cancer (r 2 5 0.99 between rs2288904
and rs3087969 in gene SLC44A2), rs4961092 and rs7001674 for pancreatic cancer (r 2 5 0.96 between rs4961092 and rs7001674 in gene ATP6V0D2).
Individual genes associated with cancer risk
We found several autophagy lysosome pathway genes associated with the risk of different types of cancers (Fig. 2) . Four genes were confirmed as significantly related to breast cancer, with a p-values <0.01 (Table 2 ). The most closely connected gene was SCARB2 (p 5 0.000027) from the gene-level analysis conducted among the autophagy lysosome pathway genes. A strong association was found in the GC analyses (GBA) and RCC analyses (ATP6V1A and GABARAP) with a p-values equal to 5.00*10
25
, exceeding the Bonferroni-corrected threshold (0.05/numbers of genes). Other genes, including ARSB and CTSZ for GC, and MAP1LC3B2 for RCC, showed statistical significance, with p < 0.01. Genes of NEU1, MANBA, CTSK and FUCA1, were confirmed to be in relation to lung cancer, with p < 0.01. We observed that there were two and one genes that were critically associated with prostate cancer and pancreatic cancer, respectively. Another two genes, VAMP1 and GABARAPL2, were significantly related to ESCC. Genes with p-values <0.05 can be found in Supporting Information Table S2 .
For the genes associated with risk of cancer, 16 genes were significant for two or more kinds of cancers, including GBA, ATP6V0D2 and CLCN6 (as shown in Fig. 3 ). Among them, three genes (GBA, ATP6V0D2 and CLCN6) showed significant association with the risk of three types of cancers.
Association of cancer risk with the autophagy lysosome pathway
In analyses by the pathway-level, the most significant relation was found to be lung cancer with p 5 0.000100. Another three significant cancers were breast cancer (p 5 0.00705), GC (p 5 0.00880) and RCC (p 5 0.00190). The remaining 
Discussion
The autophagy lysosome pathway has been widely studied in human cancer and some genetic variants of autophagy lysosome genes were identified as associated with cancer risk or prognosis. [11] [12] [13] [14] [15] [16] However, no study has comprehensively and systematically evaluated the risk of germ-line genetic variant of this pathway for cancer. In this re-analysis study of eight GWAS datasets, we identified that germ-line polymorphic variants in the autophagy lysosome pathway might be important susceptibility factors for lung cancer, GC, breast cancer and RCC. This is, to the best of our knowledge, the first report of an association between germline genetic variation of 
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the autophagy lysosome pathway and the risk of four types of cancers.
A majority of pathway-based analysis used the pathway gene-set from the publicly available pathway databases, such as BioCarta, Kyoto Encyclopedia of Genes and Genomes (KEGG) and the NCI Pathway Interaction Database. There are two pathways related to autophagy lysosome pathway, regulation of autophagy (35 genes) and lysosome (121 genes) in KEGG. In previous pathway analysis of GWAS data, the regulation of autophagy pathway or lysosome pathway was not researched or showed no significant associations with bladder cancer, breast cancer, GC, ESCC and prostate cancer. [29] [30] [31] [32] [33] In pancreatic cancer, the pathway level p-values of the regulation of autophagy pathway was 0.0254, while the pvalues of the lysosome pathway was >0.05. 34 However, the pathway definition that directly extracts genes from pathway datasets could possibly ignore some genes playing an important role in the autophagy lysosome pathway. Therefore, we chose the relatively comprehensive and systematic autophagy lysosome gene signature including 135 genes, which expanded the definition of this pathway.
Pathway-based analysis highlighted the association of polymorphic variant in the autophagy lysosome pathway with risk of lung cancer in our study. It has been reported that the variants of regulation of autophagy pathway (35 genes from KEGG) were reported to be associated with lung adenocarcinoma (p 5 0.024), but not with lung squamous-cell carcinoma in a Korean non-small cell lung cancer study, using the additive model, 35 which is partly consistent with our results. In addition, our study used the expanded autophagy lysosome gene signature (135 genes), which was more systematic. The genes that contributed to this relationship include NEU1, MANBA, CTSK and FUCA1. NEU1, the most significant gene, encodes a lysosomal enzyme which is part of a heterotrimeric complex, in the autophagy lysosome pathway. Recently, the EGFR-MUC1-NEU1 complex was reported to take part in the EGFR pathway. 36 Mutations in this gene can lead to lysosomal storage diseases. In addition, NEU1 was significantly upregulated in hepatocellular carcinoma and ovarian cancer, and NEU1 inhibition could inhibit proliferation of cancer cell. 37, 38 In our study, we found that certain SNPs in these genes were associated with lung cancer risk and genetic polymorphism of gene-level analysis also showed significant associations, which indicated that dysfunction of this protein mediated by genetic polymorphisms might be involved in tumor development. For breast cancer, there were four genes related to cancer risk that had a p < 0.01. The most significant gene was TMEM175, which encodes transmembrane protein 175. This protein forms the major lysosomal potassium channel, which regulates lumenal pH stability and is required for autophagosome-lysosome fusion. 39 The SNP rs34311866 of TMEM175 was reported to reach genomewide significance in a Parkinson's disease GWAS. 40 In our study, we found that the SNP rs2290405 of TMEM175 was the most significant SNP for breast cancer risk. The other three genes with p < 0.01 were SCARB2, ATG16L2 and TMEM63A. A functional variant of ATG16L2 was reported to be a risk allele for Crohn's disease, reaching genomewide significance. 41 However, to the best our knowledge, the four genes discussed above have not been reported in breast cancer, more researches are required to confirm these relations and explore the cellular mechanisms in breast cancer.
Our study identified three genes contributing to GC susceptibility (p < 0.01), of which GBA was the most significant (p 5 0.00005). GBA encodes a lysosomal membrane protein cleaving glucocerebroside to ceramide and glucose. Mutations in GBA were reported to be associated with Gaucher disease and familial Parkinson disease, and the SNP in GBA had a genome-wide significant association with Parkinson disease. 42, 43 The association of GBA gene polymorphic variants with GC has also been reported, which was consistent with our results. 30 However, to date GBA and its functions have not been studied in GC.
In RCC, three genes in the autophagy lysosome pathway showed significant associations with RCC risk (p < 0.01): ATP6V1A, GABARAP and MAP1LC3B2. Among them, the 44 High expression of the V1A subunit of V-ATPase was associated with poor outcome of patients with GC, and it could induce proliferation and invasion of GC cells. 45 GABARAP is one of the Atg 8 family members, which is essential for autophagy lysosome function. GABARBP was reported to be a tumor suppressor protein with regulatory function for hypoxia-inducible factor-1a and vascular endothelial growth factor expression, and thus affecting tumor angiogenesis and tumor growth. 46 Nevertheless, further studies are required to clarify the genetic polymorphism in those genes related to risk of RCC and to identify their functions in RCC development.
Although the pathway level analysis did not show significant association with risk of four cancers (bladder cancer, ESCC, pancreatic cancer and prostate cancer), there are some autophagy lysosome genes associated with the risk of these four cancers, such as VAMP1 for ESCC, ATG2A for pancreatic cancer, and SLC44A2 for prostate cancer. Three genes (GBA, ATP6V0D2 and CLCN6) showed significant association in three cancer analyses (p < 0.05). GBA was not only responsible for GC risk, but also for breast cancer and ESCC. ATP6V0D2, one of the V-ATPase-related transcripts, contributed to a high risk of breast cancer, pancreatic cancer and RCC. CLCN6 belongs to a family of the voltagedependent chloride channel protein taking part in a multitude of basal cellular processes including intracellular vesicles acidification and transepithelial transport. 47 However, no study has reported the associations of these genes with these cancers.
Our approach uncovered some interesting results, in particular cross over with other disorders including Parkinson's disease. We found that genetic variants of some autophagy lysosome genes significantly associated with cancer risk in our study were also recognized as the genetic causes of Parkinson's disease, including GBA, TMEM175 and SCARB2. 48 Our results may partly explain why patients with Parkinson's disease suffered with a higher probability of cancer occurrence in Taiwan, 49 which did not supported in US Asian Americans. 50 Although the association between cancer and Parkinson disease was inconsistent, our results may explain some similarities in pathogenesis of cancer and Parkinson disease.
Despite its novelty and strength, there were also some potential drawbacks in our study. First, there was no independent dataset as a replication set for eight types of cancers in our study; a further validation dataset must be analyzed for those associations. Although the permutation-based sampling procedure used in our study may internally mitigate this potential bias, our results may not be applicable to the general situation. Second, our analysis did not look at histopathological subtypes of cancers, because different histological subtypes might lead to distinctly different results. However, we did not have the information on the pathological type. Third, our pathway approach did not include somatic mutations in the autophagy lysosome pathway, which play a key role in the etiology of cancer, because our analysis focused on germ-line genetic alterations based on GWAS data. Fourth, we did not include enough environmental factors in the adjustment variables despite the recognition that both genetic and environmental factors have effects on an individual's risk of cancer. After additional adjustment for smoking, SNPs reaching genome-wide significance did not change their genetic effects markedly for lung cancer and bladder cancer, which also indicated that the distribution of these nongenetic risks for cancer might be independent of the genetic factors. 4, 19 However, we could not eliminate the residual confoundings by environmental reasons.
Our study identified a novel pathway related to risk of breast cancer, GC, lung cancer, renal cell carcinoma (RCC), suggesting that autophagy lysosome pathway genes play a significant role in the generation of different kinds of cancers. These associations should be evaluated in different populations and in patients with distinct clinical characteristics such as overall survival. Moreover, further fine-mappings of this pathway or certain genes are needed before clarifying the optimal variants for research into the biological mechanisms of the observed associations. The discovery of the cancer risk of the autophagy lysosome pathway may result in further studies of the pathogenesis of cancer, as well as risk prediction in cancer. 
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